Stryker Spine Receives FDA 510(k) Clearance for Serrato Pedicle Screw ORTHOFLASH Spine Stryker Spine received FDA 510(k) clearance to market the Serrato™ Pedicle Screw. Aug 16, 2017
Strategic Orthopaedic-related 510(k)s Issued in July 2017: Interbody Focus ORTHOFLASH Spine Strategic orthopaedic-related 510(k)s issued in July 2017 include:Â EIT Cellular Titanium Cages (EIT Emerging Implant Technologies), Lumbar Interbody System (HD LifeSciences), Gemini-C Hybrid Cervical Interbody System (Osseus Fusion Systems), LumFuse-TP (Precifit Medical), Anchorman Tibial Ligament Fixation (Summit Medical) Aug 16, 2017
Camber Spine Commences U.S. Launch of SPIRA Open Matrix ALIF ORTHOFLASH Spine Camber Spine Technologies received FDA 510(k) clearance and commenced U.S. launch of the SPIRA™ Open Matrix ALIF device, manufactured with additive techniques. Aug 15, 2017
Spine Wave Launches Proficient Posterior Cervical System ORTHOFLASH Spine Spine Wave commenced limited market release of the Proficient® Posterior Cervical system. Full launch is slated for early 4Q17. Aug 15, 2017
Alphatec Spine Reports 2Q17 Revenue Company Revenue The Numbers Alphatec Spine posted 2Q17 revenue of US $24.4MM, -24.4% vs. 2Q16, and 1H17 revenue of $52.4MM, -21.2% vs. 1H16. Aug 15, 2017
DJO Global Posts 2Q17 Revenue Company Revenue The Numbers DJO Global posted 2Q17 revenue of US $294.7MM, +0.6% vs. 2Q16, and 1H17 revenue of $583.1MM, +2.0% vs. 1H16. Aug 15, 2017
Expanding Orthopedics Receives Additional Patents for Interbody Cage Technology ORTHOFLASH Spine Expanding Orthopedics was granted two additional U.S. Patents covering expandable interbody cage technology. Aug 14, 2017
Renovis Receives FDA Clearance for 3D-Printed PLIF Systems ORTHOFLASH Spine Renovis Surgical received FDA 510(k) clearance to market Tesera® 3D-printed posterior lumbar interbody fusion systems. Aug 11, 2017
Orthofix Reports 2Q17 Revenue Company Revenue The Numbers Orthofix posted 2Q17 revenue of US $108.9MM, +4.7% from 2Q16, and 1H17 revenue of $211.7MM, +4.4% vs. 1H16. Aug 11, 2017
Vericel Reports 2Q17 Orthobiologic Revenue Company Revenue The Numbers Vericel posted 2Q17 orthobiologic revenue of US $12.9MM, +43.4% vs. 2Q16, and 1H17 revenue of $17.9MM, +27.9% vs. 1H16. Aug 11, 2017